About Premas Biotech Private Limited
Data last updated:
Premas Biotech Private Limited is a private limited company based in Manesar, Haryana, India, a subsidiary of Zinchlor Technologies Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 28 November 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24232HR2005PTC035932. Its GSTIN is 06AADCP7329M1Z1 (Haryana).
The company has an authorised share capital of ₹33.5 Cr and a paid-up capital of ₹23.45 Cr. It is led by directors including Prabuddha Kumar Kundu (Managing Director) and Goutam Das.
Its last annual general meeting (AGM) was held on 05 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – 79B & 80B Sector – 5, Manesar, Haryana, India – 122052.
As per the financials filed for FY 2025, the company reported a revenue of ₹45.93 Cr, a growth of 65% compared to the previous year. For the same year it recorded a net profit of ₹2.92 Cr (net margin 6.3%) and EBITDA of ₹18.38 Cr (EBITDA margin 40%).
The company has about 109 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Premas Biotech. As per MCA filings, the company has open charges of ₹32 Cr and satisfied charges of ₹1 Cr on record. Court records list 4 cases involving the company, including 4 filed by the company; 2 cases are pending. The company has 10 deals on record (5 funding rounds, 5 secondary share transfers), with disclosed funding of ₹40.75 Cr; the latest was in August 2022. Its 10 peer companies in the Pharma industry (Contract Research, Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Yash Pharma Laboratories Private Limited with revenue of ₹46.17 Cr. The company has 6 MSME Form 1 returns on record between 2022 and 2024, listing 25 overdue payments to 16 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website premasbiotech.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No – 79B & 80B Sector – 5, Manesar, Haryana, India – 122052
- IndustryPharma, Pharma Contract R&D, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Premas Biotech Private Limited
The main business activities of Premas Biotech are professional, scientific and technical and trade. In detail, this covers scientific research and development and wholesale trading. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Premas Biotech Private Limited FY 2025 filings available
Premas Biotech Private Limited reported revenue of ₹45.93 Cr (up 65% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Premas Biotech Private Limited
Revenue rose 65% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Premas Biotech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹45.93 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹18.38 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.92 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Premas Biotech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 40% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 6.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Premas Biotech are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Premas Biotech Private Limited
Premas Biotech Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research, Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Yash Pharma Laboratories Private Limited | ₹46.17 Cr (FY 2025) | •••• | •••• | -35.0% | •••• | Thane, Maharashtra, India |
| Brilliant Lifesciences Private Limited | ₹46.12 Cr (FY 2025) | •••• | •••• | 103.0% | •••• | Detroj, Gujarat, India |
| Vcherish Labs Private Limited | ₹45.95 Cr (FY 2025) | •••• | •••• | •••• | Delhi, India | |
| Distinct Impex Private Limited | ₹45.94 Cr (FY 2025) | •••• | •••• | 51.0% | •••• | Mumbai, Maharashtra, India |
| SKN Organics Private Limited | ₹45.94 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Chennai, Tamil Nadu, India |
| Premas Biotech Private Limited this company | ₹45.93 Cr (FY 2025) | •••• | •••• | 65.0% | •••• | Manesar, Haryana, India |
| Moonstar Lifecare Private Limited | ₹45.92 Cr (FY 2025) | •••• | •••• | 35.0% | •••• | Surat, Gujarat, India |
| Lucent Biotech Limited | ₹45.89 Cr (FY 2024) | •••• | •••• | 69.0% | •••• | Lucknow, Uttar Pradesh, India |
| Novagen Healthcare Private Limited | ₹45.81 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Karjan, Gujarat, India |
| Labmate (Asia) Private Limited | ₹45.59 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Chennai, Tamil Nadu, India |
| Lifecom Pharmaceuticals (India)) Private Limited | ₹45.55 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Premas Biotech by revenue in the Pharma industry (Contract Research, Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Premas Biotech Private Limited
Premas Biotech Private Limited is audited by S K PATODIA & ASSOCIATES LLP for the financial year 2025.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S K PATODIA & ASSOCIATES LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Premas Biotech Private Limited
Premas Biotech has 5 current directors and 15 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Goutam Das | Director | 12 Jul 2012 | 14 Years 2 Months | Current |
| Prabuddha Kumar Kundu | Managing Director | 17 Oct 2011 | 14 Years 11 Months | Current |
| Nupur Mehrotra Also directs: Ribbonate Technologies Private Limited | Director | 05 Jan 2018 | 8 Years 9 Months | Current |
| Saumen Chakraborty | Director | 29 Apr 2022 | 4 Years 5 Months | Current |
| Avijit Das | Director | 13 Jan 2006 | 20 Years 8 Months | Current |
Ownership and Shareholding of Premas Biotech Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Premas Biotech Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Sep 2022 | The Hongkong and Shanghai Banking Corporation Limited | ₹2 Cr | Open |
| 11 Mar 2022 | Hdfc Bank Limited | ₹15 Cr | Open |
| 07 Sep 2021 | Hdfc Bank Limited | ₹15 Cr | Open |
| 05 Jul 2013 | Canara Bank | ₹1 Cr | Satisfied |
Total charge records: 4 View all charges
Deals & Funding of Premas Biotech Private Limited
Premas Biotech Private Limited has 10 deals on record (5 funding rounds, 5 secondary share transfers), with disclosed funding of ₹40.75 Cr; the latest was in August 2022.
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2022 | Funding round | ₹20.4 Cr | Investors: 4 individuals |
| Jan 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jul 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 3 individuals |
| Sep 2014 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Mar 2013 | Funding round | ₹11.75 Cr | Investors: Zinchlor Technologies Limited, 2 individuals |
Full deal history
All 10 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Premas Biotech Private Limited
Premas Biotech Private Limited has 4 court cases on record: 4 filed by Premas Biotech. 2 cases are pending and 2 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 2 |
| District courts | 2 | 0 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Himachal Pradesh | Interim or miscellaneous application | Filed by the company against an individual | Pending |
| High Court of Himachal Pradesh | Writ petition | Filed by the company against an individual | Pending |
| District court, New Delhi, Delhi | Court case (RCA SCJ) | Filed by the company against an individual | Disposed |
| District court, New Delhi, Delhi | Civil suit | Filed by the company against an individual | Disposed |
Full case history
All 4 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Premas Biotech Private Limited
Premas Biotech Private Limited has 6 MSME Form 1 returns on record between 2022 and 2024, listing 25 overdue payments to 16 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 16)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Scigenics (India) Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Nextgen Life Sciences Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 6 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Premas Biotech Private Limited
Premas Biotech operates one associated brand: Premas Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| CDMO specializing in protein production and purification | premasbiotech.com |
Employees and EPFO Compliance at Premas Biotech Private Limited
Premas Biotech Private Limited has a workforce of 109 employees as of Oct 11, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
News related to Premas Biotech Private Limited
Recent Activity on Premas Biotech Private Limited
Premas Biotech Private Limited has 18 board changes on record since 2006: 5 appointments and 13 cessations. The latest: Saumen Chakraborty ceased to be Additional Director on 09 Sep 2022.
16 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Premas Biotech Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Premas Biotech Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Premas Biotech Private Limited
Premas Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AADCP7329M1Z1 | Haryana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Premas Biotech Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Premas Biotech Private Limited
Premas Biotech is an active private limited company based in Manesar, Haryana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 28 November 2005 (21+ years old) and is registered under CIN U24232HR2005PTC035932.
Premas Biotech reported revenue of ₹45.93 Cr for FY 2025 (up 65% YoY).
Premas Biotech has 5 current directors:
- Prabuddha Kumar Kundu - Managing Director
- Goutam Das - Director
- Nupur Mehrotra - Director
- Saumen Chakraborty - Director
- Avijit Das - Director
Premas Biotech reported a net profit of ₹2.92 Cr (net margin 6.3%) and EBITDA of ₹18.38 Cr (EBITDA margin 40%) for FY 2025, as per its filed financial statements.
The GSTIN of Premas Biotech is 06AADCP7329M1Z1, registered in Haryana.
The CIN (Corporate Identification Number) of Premas Biotech is U24232HR2005PTC035932. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Premas Biotech has 4 court cases on record: 4 filed by the company. 2 are pending. Most are in the high courts.
Premas Biotech was incorporated on 28 November 2005, making it 21+ years old. It is registered with the Registrar of Companies, Haryana.
Premas Biotech has 10 deals on record (5 funding rounds, 5 secondary share transfers), with disclosed funding of ₹40.75 Cr; the latest was in August 2022.
The peers of Premas Biotech by revenue are Yash Pharma Laboratories Private Limited, Brilliant Lifesciences Private Limited, Vcherish Labs Private Limited, Distinct Impex Private Limited, SKN Organics Private Limited and 5 more, all in the Pharma industry (Contract Research, Formulations).
Saumen Chakraborty ceased to be Additional Director on 09 Sep 2022. Saumen Chakraborty was appointed as Director on 29 Apr 2022. Devendar Agarwal ceased to be Company Secretary on 20 Sep 2018. Premas Biotech has 18 board changes on record in total.
Premas Biotech has 6 MSME Form 1 returns on record between 2022 and 2024, listing 25 overdue payments to 16 micro and small suppliers. The latest return was filed on 30 Apr 2024.